Cargando…
Bilirubin, Renal Hemodynamics, and Blood Pressure
Bilirubin is generated from the breakdown of heme by heme oxygenase and the reduction of biliverdin by the enzyme biliverdin reductase. Several large population studies have reported a significant inverse correlation between plasma bilirubin levels and the incidence of cardiovascular disease. Protec...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Research Foundation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3278997/ https://www.ncbi.nlm.nih.gov/pubmed/22347861 http://dx.doi.org/10.3389/fphar.2012.00018 |
_version_ | 1782223635092602880 |
---|---|
author | Stec, David E. Hosick, Peter A. Granger, Joey P. |
author_facet | Stec, David E. Hosick, Peter A. Granger, Joey P. |
author_sort | Stec, David E. |
collection | PubMed |
description | Bilirubin is generated from the breakdown of heme by heme oxygenase and the reduction of biliverdin by the enzyme biliverdin reductase. Several large population studies have reported a significant inverse correlation between plasma bilirubin levels and the incidence of cardiovascular disease. Protection from cardiovascular disease is also observed in patients with Gilbert’s syndrome which is a disease characterized by mutations in hepatic UGT1A1, the enzyme responsible for the conjugation of bilirubin into the bile. Despite the strong correlation between plasma bilirubin levels and the protection from cardiovascular disease, the mechanism by which increases in plasma bilirubin acts to protect against cardiovascular disease is unknown. Since the chronic antihypertensive actions of bilirubin are likely due to its renal actions, the effects of moderate increases in plasma bilirubin on renal hemodynamics as well as bilirubin’s potential effects on renal tubule function will be discussed in this review. Mechanisms of action as well as the potential for antihypertensive therapies targeting moderate increases in plasma bilirubin levels will also be highlighted. |
format | Online Article Text |
id | pubmed-3278997 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Frontiers Research Foundation |
record_format | MEDLINE/PubMed |
spelling | pubmed-32789972012-02-17 Bilirubin, Renal Hemodynamics, and Blood Pressure Stec, David E. Hosick, Peter A. Granger, Joey P. Front Pharmacol Pharmacology Bilirubin is generated from the breakdown of heme by heme oxygenase and the reduction of biliverdin by the enzyme biliverdin reductase. Several large population studies have reported a significant inverse correlation between plasma bilirubin levels and the incidence of cardiovascular disease. Protection from cardiovascular disease is also observed in patients with Gilbert’s syndrome which is a disease characterized by mutations in hepatic UGT1A1, the enzyme responsible for the conjugation of bilirubin into the bile. Despite the strong correlation between plasma bilirubin levels and the protection from cardiovascular disease, the mechanism by which increases in plasma bilirubin acts to protect against cardiovascular disease is unknown. Since the chronic antihypertensive actions of bilirubin are likely due to its renal actions, the effects of moderate increases in plasma bilirubin on renal hemodynamics as well as bilirubin’s potential effects on renal tubule function will be discussed in this review. Mechanisms of action as well as the potential for antihypertensive therapies targeting moderate increases in plasma bilirubin levels will also be highlighted. Frontiers Research Foundation 2012-02-14 /pmc/articles/PMC3278997/ /pubmed/22347861 http://dx.doi.org/10.3389/fphar.2012.00018 Text en Copyright © 2012 Stec, Hosick and Granger. http://www.frontiersin.org/licenseagreement This is an open-access article distributed under the terms of the Creative Commons Attribution Non Commercial License, which permits non-commercial use, distribution, and reproduction in other forums, provided the original authors and source are credited. |
spellingShingle | Pharmacology Stec, David E. Hosick, Peter A. Granger, Joey P. Bilirubin, Renal Hemodynamics, and Blood Pressure |
title | Bilirubin, Renal Hemodynamics, and Blood Pressure |
title_full | Bilirubin, Renal Hemodynamics, and Blood Pressure |
title_fullStr | Bilirubin, Renal Hemodynamics, and Blood Pressure |
title_full_unstemmed | Bilirubin, Renal Hemodynamics, and Blood Pressure |
title_short | Bilirubin, Renal Hemodynamics, and Blood Pressure |
title_sort | bilirubin, renal hemodynamics, and blood pressure |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3278997/ https://www.ncbi.nlm.nih.gov/pubmed/22347861 http://dx.doi.org/10.3389/fphar.2012.00018 |
work_keys_str_mv | AT stecdavide bilirubinrenalhemodynamicsandbloodpressure AT hosickpetera bilirubinrenalhemodynamicsandbloodpressure AT grangerjoeyp bilirubinrenalhemodynamicsandbloodpressure |